US Patent Issued to Revolution Medicines on March 3 for "2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors" (California Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,476, issued on March 3, was assigned to Revolution Medicines Inc. (Redwood City, Calif.).

"2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors" was invented by Elena S. Koltun (Redwood City, Calif.), Kevin Mellem (Redwood City, Calif.), Adrian Gill (Redwood City, Calif.), Gert Kiss (Redwood City, Calif.), Christopher Semko (Redwood City, Calif.), Naing Aay (Redwood City, Calif.), Andreas Buckl (Redwood City, Calif.), Ashutosh Jogalekar (Redwood City, Calif.) and Walter Won (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to inhibitors of...